A detailed history of Fiduciary Trust CO transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Fiduciary Trust CO holds 10,905 shares of PHAT stock, worth $51,798. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,905
Holding current value
$51,798
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$4.22 - $7.74 $46,019 - $84,404
10,905 New
10,905 $68,000

Others Institutions Holding PHAT

About Phathom Pharmaceuticals, Inc.


  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $186M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track Fiduciary Trust CO Portfolio

Follow Fiduciary Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.